ArticleCell death and differentiation2026
Astrocytic LCN2 mediates pathological crosstalk with neurons to promote neuronal loss in sepsis-associated encephalopathy.
Article in Cell death and differentiation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
Lipocalin-2 (LCN2) has been implicated in the pathogenesis of sepsis-associated encephalopathy (SAE). Our previous work demonstrated a significant increase in astrocyte-derived LCN2 in the hippocampal region during SAE. Notably, this elevated expression strongly correlates with neuronal loss and cognitive impairment, although the underlying mechanisms remain elusive. In our study, we demonstrate that increased secretion of LCN2 from hippocampal astrocytes in SAE mice binds to the neuronal receptor 24p3R, thereby inducing neuronal damage. Notably, the downregulation of neuronal 24p3R effectively abolished the detrimental effects of LCN2. In both lipopolysaccharide (LPS)- and cecal ligation and puncture (CLP)-induced sepsis models in C57 mice, neuronal 24p3R knockdown similarly alleviated sepsis-induced synaptic dysfunction and cognitive deficits. Moreover, elevated brain LCN2 levels during sepsis coincided with suppressed autophagy. Mechanistic studies revealed that LCN2-24p3R axis activated the neuronal mTOR-ULK1 pathway, leading to inhibition of autophagy. Importantly, the inhibition of neuronal mTOR activity restored autophagy and ameliorated mitochondrial damage and neuronal loss caused by astrocyte-derived LCN2. These findings suggest an etiopathogenic mechanism of SAE, which is initiated by the increased astrocytic secretion of LCN2, acting on neuronal 24p3R to activate the mTOR-ULK1 pathway, suppress autophagy, and promote mitochondrial dysfunction and neuronal loss, ultimately driving SAE progression. This study provides novel insights into the molecular mechanisms of astrocyte-neuron communication in SAE and identifies potential therapeutic targets for effective intervention.
Identifiers
42608542What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.